Vir Biotechnology VIR 深 滬
等待開盤 03-26 09:30:00 美东时间
8.99
+0.420
+4.90%
華盛通- 最 高9.39
- 今 開8.76
- 成交量 244.06万股
- 最 低 8.65
- 昨 收 8.57
- 總市值 14.13亿
- 52周最高 10.94
- 市盈率 靜 --
- 換手率 1.55%
- 52周最低 4.155
- 委 比 -11.94%
- 總股本 1.57亿
- 歷史最高 141.01
- 量 比 0.96
- 振 幅 8.63%
- 歷史最低 4.155
- 每 手 1
- 風險率 1.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
AI赋能智能监测、生物材料突破革新 标普生物科技ETF嘉实涨2.08%
截至3月5日10点48分，上证指数涨0.78%，深证成指涨1.63%，创业板指涨2.41%。MicroLED概念、光学光电子、电子纸等板块涨幅居前。 ETF方面...
03-05 10:57
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.
03-04 20:35
HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Raises Price Target to $20
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and raises the price target from $15 to $20.
03-04 20:02
Vir Biotechnology Raises Capital Through Public Stock Offering
An update from Vir Biotechnology ( ($VIR) ) is now available. Vir Biotechnology...
03-02 22:26
BUZZ-U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
BUZZ-U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set for a muted open on Thursday as Nvidia's
02-26 22:04
Vir Biotechnology prices $150M stock offering
Vir Biotechnology (VIR) priced its public offering of ~17.65M shares of common stock at $8.50 per share. Gross proceeds are expected to be about $150M. The underwriters have a 30-day option to buy up ...
02-26 15:22
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
美股牛股 | 绩优股大爆发！Clarivate大涨近40%；医药股PVLA涨超37%
绩优股大爆发！Clarivate大涨近40%，VIR涨超27%，是德科技涨超23%；核心产品试验迎突破性进展，医药股PVLA涨超37%>>
02-25 18:56
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
